HPV pill trial aims to clear precancerous cells without surgery
NCT ID NCT06979180
First seen Jan 15, 2026 · Last updated May 01, 2026 · Updated 14 times
Summary
This study tests whether a supplement called Papillex® can help reverse abnormal cervical cells caused by HPV in women diagnosed with mild to moderate precancer (CIN 1 or 2). Sixty women will take either Papillex® or a placebo daily for 180 days. Researchers will compare Pap smear and HPV test results to see if the supplement leads to improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KGK Science Inc.
RECRUITINGLondon, Ontario, N5Y 5V6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.